Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease

REFERENCES

• Kruger L, Mandelkow EM. Tau neurotoxicity and rescue in animal models of human Tauopathies. Curr Opin Neurobiol 2016; 36:52-8; PMID:26431808; http://dx.doi.org/10.1016/j.conb.2015.09.004
   PubMed Web of Science ®Google Scholar
• Iqbal K, Liu F, Gong CX. Tau and neurodegenerative disease: the story so far. Nat Rev Neurol 2016; 12:15-27; PMID:26635213; http://dx.doi.org/10.1038/nrneurol.2015.225
   PubMed Web of Science ®Google Scholar
• Ittner LM, Gotz J. Amyloid-beta and tau–a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 2011; 12:65-72; PMID:21193853; http://dx.doi.org/10.1038/nrn2967
   PubMed Web of Science ®Google Scholar
• Ittner A, Ke YD, van Eersel J, Gladbach A, Gotz J, Ittner LM. Brief update on different roles of tau in neurodegeneration. IUBMB Life 2011; 63:495-502; PMID:21698753; http://dx.doi.org/10.1002/iub.467
   PubMed Web of Science ®Google Scholar
• Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S, Brandner S. Tau, prions and Abeta: the triad of neurodegeneration. Acta Neuropathol 2011; 121:5-20; PMID:20473510; http://dx.doi.org/10.1007/s00401-010-0691-0
   PubMed Web of Science ®Google Scholar
• Ghetti B, Dlouhy SR, Giaccone G, Bugiani O, Frangione B, Farlow MR, Tagliavini F. Gerstmann-Straussler-Scheinker disease and the Indiana kindred. Brain Pathol 1995; 5:61-75; PMID:7767492; http://dx.doi.org/10.1111/j.1750-3639.1995.tb00578.x
   PubMed Web of Science ®Google Scholar
• Giaccone G, Mangieri M, Capobianco R, Limido L, Hauw JJ, Haik S, Fociani P, Bugiani O, Tagliavini F. Tauopathy in human and experimental variant Creutzfeldt-Jakob disease. Neurobiol Aging 2008; 29:1864-73; PMID:17560687; http://dx.doi.org/10.1016/j.neurobiolaging.2007.04.026
   PubMed Web of Science ®Google Scholar
• Bons N, Mestre-Frances N, Belli P, Cathala F, Gajdusek DC, Brown P. Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci U S A 1999; 96:4046-51; PMID:10097160; http://dx.doi.org/10.1073/pnas.96.7.4046
   PubMed Web of Science ®Google Scholar
• Piccardo P, Cervenak J, Yakovleva O, Gregori L, Pomeroy K, Cook A, Muhammad FS, Seuberlich T, Cervenakova L, Asher DM. Squirrel monkeys (Saimiri sciureus) infected with the agent of bovine spongiform encephalopathy develop tau pathology. J Comp Pathol 2012; 147:84-93; PMID:22018806; http://dx.doi.org/10.1016/j.jcpa.2011.09.004
   PubMed Web of Science ®Google Scholar
• Sikorska B, Liberski PP, Sobow T, Budka H, Ironside JW. Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease. Neuropathol Appl Neurobiol 2009; 35:46-59; PMID:18513219; http://dx.doi.org/10.1111/j.1365-2990.2008.00959.x
   PubMed Web of Science ®Google Scholar
• Lawson VA, Klemm HM, Welton JM, Masters CL, Crouch P, Cappai R, Ciccotosto GD. Gene knockout of tau expression does not contribute to the pathogenesis of prion disease. J Neuropathol Exp Neurol 2011; 70:1036-45; PMID:22002429; http://dx.doi.org/10.1097/NEN.0b013e318235b471
   PubMed Web of Science ®Google Scholar
• Chohan MO, Haque N, Alonso A, El-Akkad E, Grundke-Iqbal I, Grover A, Iqbal K. Hyperphosphorylation-induced self assembly of murine tau: a comparison with human tau. J Neural Transm (Vienna) 2005; 112:1035-47.
   PubMed Web of Science ®Google Scholar
• Dodart JC, Mathis C, Bales KR, Paul SM. Does my mouse have Alzheimer's disease? Genes Brain Behav 2002; 1:142-55; PMID:12884970; http://dx.doi.org/10.1034/j.1601-183X.2002.10302.x
   PubMed Web of Science ®Google Scholar
• Kunzi V, Glatzel M, Nakano MY, Greber UF, Van Leuven F, Aguzzi A. Unhampered prion neuroinvasion despite impaired fast axonal transport in transgenic mice overexpressing four-repeat tau. J Neurosci 2002; 22:7471-7; PMID:12196569
   PubMed Web of Science ®Google Scholar
• Andorfer C, Kress Y, Espinoza M, de Silva R, Tucker KL, Barde YA, Duff K, Davies P. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem 2003; 86:582-90; PMID:12859672; http://dx.doi.org/10.1046/j.1471-4159.2003.01879.x
   PubMed Web of Science ®Google Scholar
• Chesebro B, Race B, Meade-White K, Lacasse R, Race R, Klingeborn M, Striebel J, Dorward D, McGovern G, Jeffrey M. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog 2010; 6:e1000800; PMID:20221436
   PubMed Web of Science ®Google Scholar
• Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308:1435-9; PMID:15933194; http://dx.doi.org/10.1126/science.1110837
   PubMed Web of Science ®Google Scholar
• Asuni AA, Perry VH, O'Connor V. Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease. Biochem Soc Trans 2010; 38:545-51; PMID:20298219; http://dx.doi.org/10.1042/BST0380545
   PubMed Web of Science ®Google Scholar
• Wang GR, Shi S, Gao C, Zhang BY, Tian C, Dong CF, Zhou RM, Li XL, Chen C, Han J, et al. Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases. BMC Infect Dis 2010; 10:86; PMID:20356412; http://dx.doi.org/10.1186/1471-2334-10-86
   PubMed Web of Science ®Google Scholar
• Rubenstein R, Chang B, Petersen R, Chiu A, Davies P. T-tau and P-tau in brain and blood from natural and experimental prion diseases. PLoS One 2015; 10:e0143103; PMID:26630676
   PubMedGoogle Scholar
• Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wolfing H, Chieng BC, Christie MJ, Napier IA, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010; 142:387-97; PMID:20655099; http://dx.doi.org/10.1016/j.cell.2010.06.036
   PubMed Web of Science ®Google Scholar
• Denk F, Wade-Martins R. Knock-out and transgenic mouse models of tauopathies. Neurobiol Aging 2009; 30:1-13; PMID:17590238; http://dx.doi.org/10.1016/j.neurobiolaging.2007.05.010
   PubMed Web of Science ®Google Scholar
• Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 2008; 172:786-98; PMID:18258852; http://dx.doi.org/10.2353/ajpath.2008.070904
   PubMed Web of Science ®Google Scholar
• Ando K, Leroy K, Heraud C, Kabova A, Yilmaz Z, Authelet M, Suain V, De Decker R, Brion JP. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. Biochem Soc Trans 2010; 38:1001-5; PMID:20658993; http://dx.doi.org/10.1042/BST0381001
   PubMed Web of Science ®Google Scholar
• Rangel A, Race B, Klingeborn M, Striebel J, Chesebro B. Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing anchorless prion protein. Acta Neuropathol Commun 2013; 1:25; PMID:24252347; http://dx.doi.org/10.1186/2051-5960-1-25
   PubMed Web of Science ®Google Scholar
• Matsunaga Y, Peretz D, Williamson A, Burton D, Mehlhorn I, Groth D, Cohen FE, Prusiner SB, Baldwin MA. Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH. Proteins 2001; 44:110-8; PMID:11391773; http://dx.doi.org/10.1002/prot.1077
   PubMed Web of Science ®Google Scholar
• Klingeborn M, Race B, Meade-White KD, Rosenke R, Striebel JF, Chesebro B. Crucial role for prion protein membrane anchoring in the neuroinvasion and neural spread of prion infection. J Virol 2011; 85:1484-94; PMID:21123371; http://dx.doi.org/10.1128/JVI.02167-10
   PubMed Web of Science ®Google Scholar